Overview
Barium sulfate is an inorganic compound with the chemical formula BaSO4 . Barium sulfate occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield . This drug is used as a contrast agent in diagnostic x-ray procedures. Therapeutic advantages of barium sulfate in diagnostic procedures include both its low water solubility and high level of clearance from the body . Barium sulfate is ingested by mouth or administered rectally and combined with granules of effervescent bicarbonate to enhance distension of the GI tract, allowing for enhanced gastrointestinal tract visualization , .
Indication
Barium sulfate is a radiographic contrast agent indicated for use in computed tomography (CT) of the abdomen to delineate the gastrointestinal (GI) tract in adult and pediatric patients .
Associated Conditions
- Radiologic examination of the gastrointestinal tract
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Vizumax Diagnostics LLC | 71719-2040 | RECTAL | 960 mg in 1 g | 10/4/2021 | |
| E-Z-EM Canada Inc | 32909-750 | ORAL | 960 mg in 1 g | 4/13/2017 | |
| E-Z-EM Canada Inc | 32909-116 | ORAL | 400 mg in 1 mL | 10/9/2020 | |
| E-Z-EM Canada Inc | 32909-121 | ORAL | 400 mg in 1 mL | 10/25/2023 | |
| E-Z-EM Canada Inc | 32909-741 | ORAL | 20 mg in 1 mL | 10/12/2020 | |
| E-Z-EM Canada Inc | 32909-167 | ORAL, RECTAL | 1.05 g in 1 mL | 2/1/2021 | |
| E-Z-EM Canada Inc | 32909-186 | ORAL | 0.6 g in 1 mL | 10/15/2020 | |
| E-Z-EM Canada Inc | 32909-105 | ORAL | .81 g in 1 g | 4/30/2019 | |
| E-Z-EM Canada Inc | 32909-125 | ORAL | 400 mg in 1 mL | 10/15/2018 | |
| E-Z-EM Canada Inc | 32909-777 | ORAL | 20 mg in 1 mL | 10/12/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| READI-CAT 2 barium sulfate 20.9mg/mL oral suspension bottle (reformulation) | 129553 | Medicine | A | 7/17/2006 | |
| Stool Marker | 121175 | Medicine | A | 8/8/2005 | |
| E-Z-HD BARIUM SULFATE POWDER FOR ORAL SUSPENSION | 205168 | Medicine | A | 1/23/2013 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| CHEETAH | tyco healthcare | 02241596 | Suspension - Oral
,
Rectal | 2.2 % | 3/24/2000 |
| TONOPAQUE FOR SUSPENSION 95% | tyco healthcare | 02096684 | Powder - Rectal
,
Oral | 95 % | 12/31/1984 |
| ENTROBAR SUSPENSION 50% | tyco healthcare | 00652881 | Suspension - Oral | 50 % | 12/31/1986 |
| ENTROEASE | tyco healthcare | 02243109 | Suspension - Oral | 13 % | 5/9/2001 |
| BAROSPERSE FOR SUSP 95% | tyco healthcare | 00776629 | Powder For Suspension - Rectal
,
Oral | 95 % | 12/31/1988 |
| HD200 PLUS BARIUM SULFATE FOR SUSP 98% | tyco healthcare | 00626910 | Suspension - Oral | 98 % | 12/31/1984 |
| MEDEBAR PLUS - SUS ORL RT 56%W/W 100%W/V | tyco healthcare | 02216388 | Suspension - Rectal
,
Oral | 56 % | 5/28/1997 |
| E-Z-PAQUE POWDER FOR SUSPENSION 95% | therapex division de e-z-em canada inc | 01922173 | Powder For Solution - Rectal
,
Oral | 95 % | 12/31/1982 |
| ESOBAR CRM 65% | therapex division de e-z-em canada inc | 00613126 | Cream - Oral | 60 G / 100 G | 12/31/1984 |
| LIQUI-COAT HD - SUS ORL 210%W/V 81%W/W | tyco healthcare | 02195569 | Suspension - Oral | 210 % | 12/31/1996 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| BARILUX AD 327,25 g POLVO PARA SUSPENSION ORAL | Iberoinvesa Pharma S.L. | 73215 | POLVO PARA SUSPENSIÓN ORAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| BARILUX 764,32 g POLVO PARA SUSPENSION ORAL Y RECTAL | Iberoinvesa Pharma S.L. | 73154 | POLVO PARA SUSPENSIÓN ORAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| BARILUX 830 mg/ml SUSPENSION ORAL Y RECTAL | Avalon Laboratorios S.L. | 73212 | SUSPENSIÓN ORAL Y RECTAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| BARIGRAF 555,2 g POLVO PARA SUSPENSION RECTAL | Laboratorios Ern S.A. | 57393 | POLVO PARA SUSPENSIÓN RECTAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| BARIGRAF TAC POLVO PARA SUSPENSION ORAL | Laboratorios Ern S.A. | 73640 | POLVO PARA SUSPENSIÓN ORAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| RADIGRAF 555,2 G POLVO PARA SUSPENSION RECTAL | Juste Farma. S.L.U. | 81172 | POLVO PARA SUSPENSIÓN RECTAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Not Commercialized |
| SULFATO DE BARIO ROVI TAC 5 G/100 ML SUSPENSION ORAL | 81945 | SUSPENSIÓN ORAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized | |
| BARILUX 50 mg / ml CONCENTRADO PARA SUSPENSION ORAL Y RECTAL | Iberoinvesa Pharma S.L. | 73287 | CONCENTRADO PARA SOLUCIÓN ORAL Y RECTAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| BARIGRAF AD 333,2 g POLVO PARA SUSPENSION ORAL | Laboratorios Ern S.A. | 57391 | POLVO PARA SUSPENSIÓN ORAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Commercialized |
| RADIGRAF AD 333,2 G POLVO PARA SUSPENSION ORAL | Juste Farma. S.L.U. | 81221 | POLVO PARA SUSPENSIÓN ORAL | Uso Hospitalario Y Centros De Diagnóstico Autorizados | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.